Stockreport

More on MRK's HIV-1 Program [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF regimen of doravirine/islatravir (DOR/ISL) in virologically suppressed adults with HIV-1 infection. The phase III MK-8591A-051 and MK-8591A-052 studies evaluated DOR/I [Read more]